In a patient in whom you suspect MAC lung infection, what is the preponderance of evidence and symptomatology you require to initiate antimicrobial therapy for NTM lung disease? Do all patients with MAC lung disease require treatment?

In a patient in whom you suspect MAC lung infection, what is the preponderance of evidence and symptomatology you require to initiate antimicrobial therapy for NTM lung disease? Do all patients with MAC lung disease require treatment?

In a patient in whom you suspect MAC lung infection, what is the preponderance of evidence and symptomatology you require to initiate antimicrobial therapy for NTM lung disease? Do all patients with MAC lung disease require treatment? 


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina